Harvard Bioscience to Present at Benchmark Company’s Discovery One-On-One Investor Conference on December 7, 2023

Rhea-AI Summary

Harvard Bioscience, Inc. (Nasdaq: HBIO) to Present at Benchmark Company 12th Annual Discovery One-on-One Investor Conference

Positive

• Participating in one-on-one meetings with investors and analysts offers the company access to institutional and individual investors for potential growth opportunities.
• The presence of the Chairman, CEO, and CFO at the conference indicates the company's commitment to investor relations and transparency.

Negative

• None.

HOLLISTON, Mass., Nov. 20, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced it will be presenting at the Benchmark Company 12^th Annual Discovery One-on-One Investor Conference to be held Thursday December 7th, 2023 at the New York Athletic Club in New York City.

The conference offers emerging growth and dynamic publicly traded companies access to institutional and individual investors in a unique one-on-one format during which Jim Green, Chairman and Chief Executive Officer, will be participating in one-on-one meetings with investors and analysts throughout the day. Joining him will be Jennifer Cote, the company’s Chief Financial Officer and Treasurer.

To schedule a one-on-one meeting with Harvard Bioscience, Inc., you may submit your request online via the link provided upon registration. To register for the conference, please visit https://www.meetmax.com/sched/event_99181/investor_reg_new.html?attendee_role_id=INVESTOR

About Harvard Bioscience

Harvard Bioscience, Inc. is a leading developer, manufacturer and seller of technologies, products and services that enable fundamental advances in life science applications, including research, pharmaceutical and therapy discovery, bio-production and preclinical testing for pharmaceutical and therapy development. Our customers range from renowned academic institutions and government laboratories to the world’s leading pharmaceutical, biotechnology and contract research organizations. With operations in North America, Europe, and China, we sell through a combination of direct and distribution channels to customers around the world.
www.harvardbioscience.com.

Investor Inquiries:
Investors@harvardbioscience.com
(508) 893-3120

About The Benchmark Company

The Benchmark Company is an institutionally focused, research driven, sales trading and investment banking firm. We were founded in 1988 and are headquartered in New York City. Our focus is on fostering the long-term success of our corporate clients through raising capital, providing strategic advisory services, generating insightful research, and developing institutional sponsorship by leveraging the firm’s sales, trading, and equity research capabilities.
https://www.benchmarkcompany.com.

FAQ

What is the event Harvard Bioscience, Inc. will be presenting at?

Harvard Bioscience, Inc. will be presenting at the Benchmark Company 12th Annual Discovery One-on-One Investor Conference.

When and where will the conference be held?

The conference will be held on Thursday, December 7th, 2023, at the New York Athletic Club in New York City.

Who will be participating in the one-on-one meetings at the conference?

Jim Green, Chairman and Chief Executive Officer, and Jennifer Cote, the company’s Chief Financial Officer and Treasurer, will be participating in one-on-one meetings with investors and analysts throughout the day.

How can one schedule a one-on-one meeting with Harvard Bioscience, Inc.?

To schedule a one-on-one meeting, interested parties may submit their request online via the link provided upon registration for the conference.

Where can one register for the conference?

To register for the conference, interested individuals may visit https://www.meetmax.com/sched/event_99181/investor_reg_new.html?attendee_role_id=INVESTOR